Table 1.

Characteristics of accelerated approval disclosures on direct-to-consumer websites for brand-name prescription drugs (n = 19).

	n	%
Presented with the indication	19	100
Presented with largest, most central claim	2	10
Used exact language from the Prescribing Information	4	21
Elements mentioned
Accelerated approval status	1	5
Approval basis	16	84
Unknown outcomes	13	68
Ongoing or future research	9	47
Used consumer-friendly language	10	53
Used medical terms	15	79
Defined medical terms	2	10
	Mean	Standard deviation
Flesch-Kincaid grade level	11.6	2.1
Flesch reading ease test (0–100, higher = easier to read)	39.0	16.0
Number of words	34.5	13.1